References
- Balkans States Map and Information Page [Internet]; 2016. http://www.worldatlas.com/webimage/countrys/europe/balkans.htm. Accessed February 27, 2017
- World Bank Country and Lending Groups – World Bank Data Help Desk [Internet]; 2016. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed February 28, 2017
- EUROPA - Countries [Internet]. https://europa.eu/european-union/about-eu/countries_en. Accessed February 28, 2017
- Jakovljevic MM, Arsenijevic J, Pavlova M, et al. Within the triangle of healthcare legacies: comparing the performance of South-Eastern European health systems. J Med Econ 2017;20:483-92
- Jakovljevic MB. Resource allocation strategies in Southeastern European health policy. Eur J Health Econ 2013;14:153-9
- Koçkaya G, Wertheimer A. Pharmaceutical market access in emerging markets. Torino, Italia: SEEd; 2016. 239 p
- Catic T. Differences in reimbursement prices and inequalities to access most commonly prescribed medicines in Bosnia and Herzegovina. Value Health 2015;18:A527
- Rancic N, Kovacevic A, Dragojevic-Simic V. Long-term health expenditure changes in selected Balkan countries. Front Public Health 2015;3:152
- Morgan S. The determinants of prescription drug expenditure … and what to do about them. 2014. https://open.library.ubc.ca/cIRcle/collections/ubccommunityandpartnerspublicati/47136/items/1.0048391. Accessed February 27, 2017
- Elseviers M, Andersen M, Benko R, et al. Drug utilization research: Methods and applications. Chichester, West Sussex: Hoboken, NJ: John Wiley & Sons; 2016
- Vogler S, Zimmermann N, Habl C. Understanding the components of pharmaceutical expenditure—overview of pharmaceutical policies influencing expenditure across European countries. Generics Biosimilars Initiat J 2013;2:178-87
- Lu Y, Hernandez P, Abegunde D, et al. The world medicines situation 2011. Med Expend World Health Organ Geneva [Internet]. 2011. http://www.who.int/entity/health-accounts/documentation/world_medicine_situation.pdf?ua=1. Accessed February 28, 2017
- Annex: The World Medicines Situation 2011 - Medicine Expenditures. World Health Organization. [Internet]. 2011. http://apps.who.int/medicinedocs/en/m/abstract/Js20052en/. Accessed February 28, 2017
- Keegan C, Thomas S, Normand C, et al. Measuring recession severity and its impact on healthcare expenditure. Int J Health Care Finance Econ 2013;13:139-55
- Impact of the Economic Recession on the Pharmaceutical Sector [Internet]; 2010. http://apps.who.int/medicinedocs/en/m/abstract/Js17419e/. Accessed March 1, 2017
- Leopold C, Mantel-Teeuwisse AK, Vogler S, et al. Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries. Bull World Health Organ 2014;92:630-640D
- Jakovljevic M, Souliotis K. Pharmaceutical expenditure changes in Serbia and Greece during the global economic recession. South East Eur J Public Health 2016;5. DOI: 10.4119/UNIBI/SEEJPH-2016-101
- Souliotis K, Papageorgiou M, Politi A, et al. Estimating the fiscal effects of public pharmaceutical expenditure reduction in Greece. Front Public Health 2015;3:203
- Jakovljevic MB, Djordjevic N, Jurisevic M, et al. Evolution of the Serbian pharmaceutical market alongside socioeconomic transition. Expert Rev Pharmacoecon Outcomes Res 2015;15:521-30
- The Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina. Report on consumption of market authorized medicines in 2009 in Bosnia and Herzegovina [Internet]. Banja Luka: The Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina; 2010. http://www.almbih.gov.ba/_doc/publikacije/PrometLijekova2009BiH.pdf. Accessed March 2, 2017
- The Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina. Report on consumption of market authorized medicines in 2015 in Bosnia and Herzegovina [Internet]. Banja Luka: The Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina; 2016. http://www.almbih.gov.ba/_doc/publikacije/promet2015.pdf. Accessed March 2, 2017
- Agency for Medicinal Products and Medical Devices of Croatia. Annual Report on Drug Consumption for 2007 [Internet]. Zagreb: HALMED; 2008. http://www.halmed.hr/Novosti-i-edukacije/Publikacije-i-izvjesca/Izvjesca-o-potrosnji-lijekova/Izvjesce-o-prometu-lijekova-u-Republici-Hrvatskoj-u-2007/. Accessed March 2, 2017
- Agency for Medicinal Products and Medical Devices of Croatia. Annual Report on Drug Utilisation for 2015 [Internet]. Zagreb: HALMED; 2016. http://halmed.hr/Novosti-i-edukacije/Publikacije-i-izvjesca/Izvjesca-o-potrosnji-lijekova/Izvjesce-o-potrosnji-lijekova-u-Republici-Hrvatskoj-u-2015/. Accessed March 2, 2017
- Agency for Medicines and Medical Devices of Montenegro. Report on medicines consumption in Montenegro in 2009 [Internet]. 2010. https://www.calims.me/Portal/faces/dinamickeStrane?_afrWindowMode=0&_afrLoop=26718080599316225¶mRender=1¶mS=67&_adf.ctrl-state=x7e7e7y5r_121. Accessed March 2, 2017
- Agency for Medicines and Medical Devices of Montenegro. Report on medicines consumption in Montenegro in 2015 [Internet]. Agency for Medicines and Medical Devices of Montenegro; 2016. https://www.calims.me/Portal/faces/dinamickeStrane?_afrWindowMode=0¶mS=168&_afrLoop=26718081683561422¶mRender=1&_adf.ctrl-state=x7e7e7y5r_130. Accessed March 2, 2017
- OECD. OECD Health Statistics 2014 How does Slovenia compare? [Internet]. 2014. http://www.oecd.org/els/health-systems/Briefing-Note-SLOVENIA-2014.pdf. Accessed March 1, 2017
- Cylus J. Analysis of the Health System in Slovenia. Health System Expenditure Review. Final Report. [Internet]. 2015. http://www.mz.gov.si/fileadmin/mz.gov.si/pageuploads/Analiza/Report_Expenditure_review_Slovenia_FINAL_FORMATTED_without_cover.pdf. Accessed March 1, 2017
- Džakula A, Sagan A, Pavić N, et al. Croatia: Health system review. Health Syst Transit 2014;16:1-162
- Godman B, Kwon H-Y, Brkičić LS, et al. Pharmaceutical pricing in Croatia: a comparison of ordinances in 2013 versus 2009 and their potential savings to provide future guidance. Generics Biosimilars Initiat J 2015;4:79-89
- Yılmaz ES, Koçkaya G, Yenilmez FB, et al. Impact of health policy changes on trends in the pharmaceutical market in Turkey. Value Health Reg Issues 2016;10:48-52
- Avdi E. The effect of pricing policies and cost-containment measures in Albanian health insurance scheme. Romanian Econ Bus Rev 2013;8:61
- Dimova A, Rohova M, Moutafova E, et al. Bulgaria: Health system review. Health Syst Transit 2012;14:1-186
- Iskrov G, Stefanov R. Prospects of risk-sharing agreements for innovative therapies in a context of deficit spending in Bulgaria. Front Public Health 2015;3:64
- Vlădesc C, Scîntee SG, Olsavszky V, et al. Romania: health system review. Health Syst Transit 2016;18:1-170
- EuroREACH. WP4 International Health Data Systems – draft [Internet]; 2011. http://www.euroreach.net/sites/default/files/WP4%20International%20Health%20Data%20Systems%20Deliverable.pdf. Accessed March 13, 2017
- OECD. Pharmaceutical spending (indicator). [Internet]; 2017. OECD. http://data.oecd.org/healthres/pharmaceutical-spending.htm. Accessed March 13, 2017
- European Health for All Database (HFA-DB) [Internet]; 2016. http://data.euro.who.int/hfadb/. Accessed March 13, 2017
- Gerdtham UG, Johannesson M, Jönsson B. Drug expenditure and new drug introductions: the Swedish experience. Pharmacoeconomics 1993;4:215-25
- Gerdtham UG, Lundin D. Why did drug spending increase during the 1990s? A decomposition based on Swedish data. Pharmacoeconomics 2004;22:29-42
- Lambrelli D, O’Donnell O. The impotence of price controls: failed attempts to constrain pharmaceutical expenditures in Greece. Health Policy 2011;101:162-71
- Kajdiž R, Bojnec Š. Determinants of public expenditures for medicinal products in non hospital consumption in Slovenia. EM Ekon Manag 2014;17:27-34
- OECD. Tackling Wasteful Spending on Health [Internet]. OECD Publishing; 2017. http://www.oecd-ilibrary.org/social-issues-migration-health/tackling-wasteful-spending-on-health_9789264266414-en. Accessed March 2, 2017
- Belloni A, Morgan D, Paris V. Pharmaceutical expenditure and policies [Internet]. Paris: Organisation for Economic Co-operation and Development; 2016. http://www.oecd-ilibrary.org/;jsessionid=9ed8987pnsqh9.x-oecd-live-03content/workingpaper/5jm0q1f4cdq7-en. Accessed February 28, 2017
- Jakovljevic MB, Milovanovic O. Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS. Front Public Health 2015;3:65
- Jakovljevic MB, Vukovic M, Fontanesi J. Life expectancy and health expenditure evolution in Eastern Europe-DiD and DEA analysis. Expert Rev Pharmacoecon Outcomes Res 2016;16:537-46
- Jakovljevic M, Laaser U. Population aging from 1950 to 2010 in seventeen transitional countries in the wider region of South Eastern Europe. SEEJPH 2015;3. DOI: 10.4119/UNIBI/SEEJPH-2015-49